Latest News

Why the Lefay joint venture matters for Marriott International (MAR) The newly announced joint venture with Lefay puts Marriott International (MAR) directly into luxury wellness hospitality, giving the group its first brand focused solely on holistic wellbeing and eco-resorts. This move connects Lefay's wellness philosophy and Italian resort portfolio with Marriott's Marriott Bonvoy platform and development capabilities. It is a combination that could influence how investors think about the...

Pinnacle West Capital (PNW) has drawn fresh attention after recent trading left the share price at $102.70. This has put a spotlight on how its Arizona focused regulated electricity business lines up with recent return trends. See our latest analysis for Pinnacle West Capital. The recent 1-day share price return of 1.15% and 7-day share price return of 3.02% sit alongside a 90-day share price return of 17.10%. The 1-year total shareholder return of 17.30% and 5-year total shareholder return...

Reprocessing deal with Orano puts Kansai Electric in focus Orano’s January 20, 2026 agreement with NuRO to reprocess around 200 metric tons of spent fuel from Kansai Electric Power Company (TSE:9503) reactors in France has put fresh attention on the utility’s nuclear footprint. The deal, covering work at Orano’s La Hague plant and waste conditioning for return to Japan, could shape how you think about Kansai Electric’s long term fuel cycle commitments and its role in global nuclear...

LaSalle LOGIPORT REIT (TSE:3466) has moved ahead with its board-approved investment unit buyback, repurchasing 28,670 units in March 2026 under an authorization of up to 84,000 units through February 2027. See our latest analysis for LaSalle LOGIPORT REIT. The recent buyback comes as LaSalle LOGIPORT REIT’s share price sits at ¥150,800, with a 1-day share price return of 1.00%. However, the year to date share price return shows a 4.98% decline, while the 1-year total shareholder return of...

Why THK Is On Investors’ Radar Today THK (TSE:6481) is back on screens after a sharp move in recent performance, with the share price showing strong gains over the past year alongside reported revenue and net income figures. See our latest analysis for THK. Recent trading has been mixed, with a 2.48% 1 day share price return and a 22.63% 90 day share price return standing against a slightly negative 30 day move. The 1 year total shareholder return of 59.70% points to building momentum...

In late April 2026, Ventas, Inc. released its first‑quarter 2026 results and hosted an investor conference call with webcast and replay access following the close of New York Stock Exchange trading. At the same time, Baron Capital’s Baron Real Estate Income Fund increased its Ventas holdings, underscoring institutional confidence in the company’s senior housing focus and an external growth pipeline expected to exceed US$2.50 billion in 2026. We’ll now examine how this increased institutional...

Shionogi & Co., Ltd. has completed the acquisition of all rights to the ALS treatment RADICAVA (edaravone) from Tanabe Pharma, consolidating intellectual property and commercial control in major markets and expanding its rare disease portfolio. This move effectively transforms Shionogi into a broader rare disease player by integrating RADICAVA’s commercial platform, infrastructure, and specialist teams into its global operations. We’ll now examine how the RADICAVA rights transfer and...

Why Prologis Stock Is Back in Focus Prologis (PLD) is drawing fresh attention after amending its global credit facilities to secure up to US$3b in revolving, multicurrency capacity. Earnings estimate upgrades and rating changes are also building interest ahead of the April 16 report. See our latest analysis for Prologis. The stock has been relatively steady over the past month, but a 3.78% 7 day share price return and a 40.91% 1 year total shareholder return indicate that momentum has been...

In recent days, Freedom Capital Markets analyst Ilya Zubkov initiated coverage on IRadimed (IRMD.US) with a buy rating, marking fresh analyst attention on the medical device maker. An interesting wrinkle is that this new positive view comes from an analyst whose prior-year track record shows a success rate of 16.7% and an average return of 21.0% in the wrong direction, which may temper how investors interpret the endorsement. Now we’ll examine how this new, positive analyst coverage might...

Ashtrom Group (TASE:ASHG) has announced an annual dividend of ₪0.8966 per share, with an ex date and record date set for April 6, 2026, and payment scheduled for April 15, 2026. See our latest analysis for Ashtrom Group. The upcoming dividend comes after a period where momentum has cooled slightly, with a 1 day share price return of 3.75% at ₪71.08 but a year to date share price return of a 2.23% decline, while the 1 year total shareholder return of 36.22% points to stronger longer term...

In March 2026, Rogers Communications Inc. completed a $750,000,000 fixed-to-floating rate, unsecured, guaranteed Eurobond offering of callable senior subordinated notes due July 31, 2056, priced at 100% with a 1% discount per security and a variable coupon. On the same day, TD Securities downgraded Rogers on concerns that intensifying wireless price competition and rising customer churn could pressure earnings and reshape expectations for its long-term growth fundamentals. We'll now examine...

Viper Energy recently reported year-over-year revenue growth that outpaced peers and topped analyst expectations, supported by successful integration of newly acquired mineral and royalty assets in the Permian Basin. At the same time, stronger crude and natural gas liquids pricing, together with Viper’s capital‑light royalty model, has amplified the earnings impact of its expanded portfolio. With that backdrop, we’ll now consider how stronger-than-expected revenue performance under higher...

Tuas Limited recently reported half-year results for the period ended January 31, 2026, with sales of S$91.91 million and net income of S$8.23 million, both higher than a year earlier. The company’s basic earnings per share from continuing operations roughly doubled year-on-year, highlighting a meaningful uplift in profitability during the period. Next, we’ll examine how this sharper earnings performance, especially the jump in net income, may influence Tuas Limited’s broader investment...

TransUnion (TRU) has rolled out TruIQ Credit Strategy Studio and expanded its relationship with MRI-Simmons, giving lender and advertiser clients new tools to design, test and activate campaigns within unified data and workflow environments. See our latest analysis for TransUnion. These launches and partnerships come as TransUnion’s share price trades at US$69.32, with a 7 day share price return of 5.41% after a weaker 30 day and 90 day stretch. The 3 year total shareholder return of 14.72%...

V2X, Inc. recently appointed Mike Uster as Chief Information Officer, tasking him with leading global IT strategy, cybersecurity, and AI-enabled digital transformation to support the company’s mission-critical defense operations. Uster’s long track record implementing zero-trust architectures and AI-driven capabilities for government and defense clients could materially influence how V2X modernizes its technology backbone for complex contracts worldwide. We’ll now examine how Uster’s...

Why GameStop Matters For Retail Investors Right Now GameStop (GME) has stayed in the spotlight as a specialty retailer focused on games, collectibles and entertainment products, with investors watching how recent share price swings align with its current business footprint. See our latest analysis for GameStop. With the share price at $23.36, GameStop has seen a 2.64% 1 day share price return and a 12.74% 90 day share price return, while the 1 year total shareholder return sits at 0.61%,...

Erie Indemnity (ERIE) is back in focus as investors look ahead to its upcoming fiscal Q1 2026 earnings, following weaker Q4 2025 results and a mixed track record against recent quarterly expectations. See our latest analysis for Erie Indemnity. The upcoming Q1 2026 release comes after a weak Q4 and a clear loss of momentum, with a 90 day share price return decline of 11.5% and a 1 year total shareholder return loss of 36%, even though the stock has bounced 3.6% over the past week to...

Recent analyst commentary around HCA Healthcare (HCA) has centered on its 2026 guidance, connecting executive incentive plans, hospital expansion projects, artificial intelligence tools, and new service lines that some investors view as important potential growth drivers. See our latest analysis for HCA Healthcare. The recent 11.4% 1 month share price decline to around $471.84 comes after a strong 1 year total shareholder return of 43.2%. This suggests shorter term momentum has cooled even as...

What Dalipal’s Latest Earnings Mean for Shareholders Dalipal Holdings (SEHK:1921) moved back into profit for 2025, reporting CNY 3,462.49 million in sales and net income of CNY 13.72 million after a net loss in the prior year. Basic and diluted earnings per share from continuing operations reached CNY 0.01, compared with a basic and diluted loss per share of CNY 0.05 previously. This shift can influence how you view the stock’s risk and return profile. See our latest analysis for Dalipal...

In March 2026, Element Solutions Inc. reported that Executive Chairman Sir Martin E. Franklin would step down and not seek re-election at the 2026 Annual Meeting, with long-time director Ian G.H. Ashken set to become Non-Executive Chairman. Around the same time, high-profile commentary from Jim Cramer spotlighted Element Solutions’ growth outlook and valuation in specialty chemicals, bringing renewed attention to its role in advanced electronics and semiconductor markets. With Jim Cramer...

T. Rowe Price Group (TROW) has appointed Bill Cashel as Head of Alternatives for U.S. Wealth, a move focused on expanding its alternative and private market offering for retirement and wealth investors. See our latest analysis for T. Rowe Price Group. The appointment of a dedicated alternatives head comes as T. Rowe Price Group’s share price has eased in recent months, with a 90-day share price return of a 15.33% decline and a year-to-date share price return of a 13.82% decline, while the...

In recent weeks, BKV Corporation has drawn fresh attention as Jim Cramer highlighted its natural gas, power generation and carbon capture businesses against a backdrop of shifting Middle East geopolitics and rising focus on U.S. LNG exports. At the same time, revised analyst earnings expectations and BKV’s push to lock in long-term power contracts at its Temple Energy Complex underscore how investor debate is increasingly centered on the durability and visibility of its future cash...

In late March and early April 2026, Applied Optoelectronics Inc. announced that a major hyperscale customer expanded its 800G single‑mode data center transceiver orders to US$124 million, while earlier also securing an over US$200 million volume order for 1.6T modules and beginning initial 800G shipments to a second hyperscale client. Together, these large AI‑oriented transceiver commitments significantly increase Applied Optoelectronics’ backlog and highlight how its vertically integrated...

Spyre Therapeutics (SYRE) recently accelerated its Phase 2 SKYWAY basket trial by completing enrollment for the rheumatoid arthritis sub study of SPY072 ahead of schedule, with topline data now guided for Q3 2026. See our latest analysis for Spyre Therapeutics. The accelerated SKYWAY timeline comes on top of a sharp run, with Spyre Therapeutics posting a 30 day share price return of 18.51% and a 90 day share price return of 58.81%. The 1 year total shareholder return of 272.01% and 3 year...